TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 62 filers reported holding TITAN PHARMACEUTICALS INC DE in Q3 2016. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $89,000 | – | 15,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 545,000 | $122,000 | 0.10% |
| Virtu Financial LLC | 236,182 | $53,000 | 0.00% |
| Planning Solutions Group LLC | 14,293 | $3,000 | 0.00% |
| Cutter & CO Brokerage, Inc. | 10,000 | $2,000 | 0.00% |
| Blume Capital Management, Inc. | 2,546 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 17,483 | $4,000 | 0.00% |
| Wealthspire Advisors, L.P. | 8,235 | $2,000 | 0.00% |
| Advisor Group, Inc. | 2,100 | $0 | 0.00% |
| FLAGSHIP HARBOR ADVISORS, LLC | 2,250 | $0 | 0.00% |